Drugs / CMV Cytotoxic T-Lymphocytes
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05564598 | Jul 2023 → Oct 2027 expected | fetal cytomegalovirus syndrome | New York Medical College | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CMV Cytotoxic T-Lymphocytes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05564598 ↗ |
| Modality | Cell therapy | “CMV Cytotoxic T-Lymphocytes” NCT05564598 ↗ |